LATHAM HOUSE MEDICAL PRACTICE
SAGE CROSS STREET, MELTON MOWBRAY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 108 | 117 | 92.3% | |
| HF 4 | 2011 | 109 | 124 | 87.9% | |
| HF 4 | 2012 | 114 | 132 | 86.4% | |
| HF 4 | 2013 | 121 | 132 | 91.7% | |
| HF004 | 2014 | 33 | 35 | 94.3% | |
| HF004 | 2015 | 40 | 41 | 97.6% | |
| HF004 | 2016 | 38 | 39 | 97.4% | |
| HF004 | 2017 | 88 | 93 | 94.6% | |
| HF004 | 2018 | 95 | 103 | 92.2% | |
| HF004 | 2019 | 97 | 115 | 84.3% | |
| HF004 | 2020 | 99 | 106 | 93.4% | |
| HF006 | 2021 | 157 | 167 | 94.0% | |
| HF006 | 2022 | 171 | 175 | 97.7% | |
| HF006 | 2023 | 185 | 195 | 94.9% |
